Cerebrospinal fluid biomarkers in neurodegenerative disorders

Thalia T. Robey, Peter K. Panegyres

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Neurodegenerative diseases represent a daunting challenge in clinical diagnosis and management. Biomarkers that might aid in the diagnosis of these devastating and globally important diseases are urgently sought and required. Here we describe the application and state of development of a range of cerebrospinal fluid biomarkers in common neurodegenerative disorders including Alzheimer's disease, frontotemporal dementia and prion diseases.

Original languageEnglish
JournalFuture Neurology
Volume14
Issue number1
DOIs
Publication statusPublished - 1 Feb 2019

Fingerprint

Neurodegenerative Diseases
Cerebrospinal Fluid
Biomarkers
Frontotemporal Dementia
Prion Diseases
Alzheimer Disease

Cite this

@article{c5a628eeaf524ae6a1445bd089f20c80,
title = "Cerebrospinal fluid biomarkers in neurodegenerative disorders",
abstract = "Neurodegenerative diseases represent a daunting challenge in clinical diagnosis and management. Biomarkers that might aid in the diagnosis of these devastating and globally important diseases are urgently sought and required. Here we describe the application and state of development of a range of cerebrospinal fluid biomarkers in common neurodegenerative disorders including Alzheimer's disease, frontotemporal dementia and prion diseases.",
keywords = "Alzheimer's disease, Biomarker, Cerebrospinal fluid, Dementia, Neurodegenerative disease",
author = "Robey, {Thalia T.} and Panegyres, {Peter K.}",
year = "2019",
month = "2",
day = "1",
doi = "10.2217/fnl-2018-0029",
language = "English",
volume = "14",
journal = "Future Neurology",
issn = "1479-6708",
publisher = "Future Medicine Ltd",
number = "1",

}

Cerebrospinal fluid biomarkers in neurodegenerative disorders. / Robey, Thalia T.; Panegyres, Peter K.

In: Future Neurology, Vol. 14, No. 1, 01.02.2019.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Cerebrospinal fluid biomarkers in neurodegenerative disorders

AU - Robey, Thalia T.

AU - Panegyres, Peter K.

PY - 2019/2/1

Y1 - 2019/2/1

N2 - Neurodegenerative diseases represent a daunting challenge in clinical diagnosis and management. Biomarkers that might aid in the diagnosis of these devastating and globally important diseases are urgently sought and required. Here we describe the application and state of development of a range of cerebrospinal fluid biomarkers in common neurodegenerative disorders including Alzheimer's disease, frontotemporal dementia and prion diseases.

AB - Neurodegenerative diseases represent a daunting challenge in clinical diagnosis and management. Biomarkers that might aid in the diagnosis of these devastating and globally important diseases are urgently sought and required. Here we describe the application and state of development of a range of cerebrospinal fluid biomarkers in common neurodegenerative disorders including Alzheimer's disease, frontotemporal dementia and prion diseases.

KW - Alzheimer's disease

KW - Biomarker

KW - Cerebrospinal fluid

KW - Dementia

KW - Neurodegenerative disease

UR - http://www.scopus.com/inward/record.url?scp=85064971169&partnerID=8YFLogxK

U2 - 10.2217/fnl-2018-0029

DO - 10.2217/fnl-2018-0029

M3 - Article

VL - 14

JO - Future Neurology

JF - Future Neurology

SN - 1479-6708

IS - 1

ER -